Viatris Inc (VTRS) Form 10-K Annual Reports
Viatris Inc (VTRS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VTRS
CIK: 1792044
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerMelissa Cloniger
Audit LocationPittsburgh, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SC TO-C | 2026-10-08 | — | SC TO-C | 0001140361-26-039148 | View SEC Doc Filr Page |
| SC TO-C | 2026-10-08 | — | SC TO-C | 0001140361-26-039025 | View SEC Doc Filr Page |
| 8-K | 2026-10-08 | 2026-10-08 | 8-K | 0001140361-26-039024 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001140361-26-038451 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001140361-26-038449 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-08 | — | SCHEDULE 13G/A Filing | 0000315066-26-002299 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-15 | FORM 4 | 0001140361-26-033613 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0001036325-26-000023 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001792044-26-000041 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0000315066-26-002166 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001792044-26-000037 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0001140361-26-027263 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0001140361-26-027262 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-07-01 | 8-K | 0001140361-26-027216 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-25 | FORM 4 | 0001140361-26-026593 | View SEC Doc Filr Page |
| 144 | 2026-06-25 | — | 144 Filing | 0001628280-26-045540 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-17 | 8-K | 0001140361-26-025744 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-12 | 8-K | 0001140361-26-025228 | View SEC Doc Filr Page |
| 424B5 | 2026-06-15 | — | 424B5 | 0001140361-26-025215 | View SEC Doc Filr Page |
| FWP | 2026-06-12 | — | FWP | 0001140361-26-025065 | View SEC Doc Filr Page |
| 424B5 | 2026-06-12 | — | 424B5 | 0001140361-26-024994 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | 8-K | 0001140361-26-021672 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001792044-26-000029 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001792044-26-000025 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-05 | — | SCHEDULE 13G/A Filing | 0001036325-26-000013 | View SEC Doc Filr Page |